VACCINE MENINGOCOCCAL A CONJUGATE, 1-29years, 1dose,multid.v
Valid Article
VACCINE MENINGITIS A CONJUGATE 1-29 years
CAUTION
This multidose vaccine is worded and codified by unit (= 1 dose) to make the order easier.
Full Name
MenAfriVac 10µg®
Therapeutic Action
Freeze-dried vaccine inducing the production of bactericidal antibodies specific to the capsular polysaccharides of Neisseria meningitidisserogroup A.
Indications
Active immunisation against meningitis due to Neissseria meningitidis group A in children, adolescents and adults from 1 to 29 years of age.
For routine immunisation, use the meningococcal A conjugate vaccine 3-24 months (MenAfriVac 5µg®).
The countries that have already introduced a monovalent meningococcal A conjugate vaccine into their routine programme should progressively switch to the ACYWX conjugate vaccine (MenFive®).
The vaccine needs to be registered in the country.
Instructions for use
Reconstitute the powder vial with the diluent supplied by the manufacturer.
1 dose = 0.5 ml reconstituted suspension = 10 µg meningococcal polysaccharide
Must be given as IM injection into the anterolateral part of the thigh in children < 2 years or into the deltoid muscle in children ≥ 2 years and adults.
Do not forget to order the diluent (1-29 y) together with the vaccine!
Orders are always done in number of doses and not in number of vials! (See Preliminary remarks on Vaccines)
Precautions for Use
As with all injectable vaccines and/or immunoglobulins, appropriate medical treatment should always be readily available in case of rare anaphylactic reactions following the administration of the product.
Storage
- Do not freeze.
- Powder: between 2°C and 8°C - Protect from sunlight
- Diluent: cold chain is not required for storage. However, at least 12 hrs before reconstitution of the vaccine, the diluent must be refrigerated between 2ºC and 8ºC so that the diluent and lyophilised powder are at the same temperature (a thermic shock during reconstitution could reduce the vaccine efficacy).
- Vaccine reconstituted: between 2°C and 8°C for 6 hrs maximum, protected from the light
- During mass vaccination campaign only, the MenAfriVac 10µg®vaccine can be stored in a controlled temperature chain (CTC), for up to 4 days at temperature not exceeding 40ºC, immediately prior administration. Unopened vials should be discarded at the end of the 4 days at 40ºC or if exposed to > 40ºC. (See Preliminary remarks on Vaccines)
- The vaccine vial monitor (VVM) is mandatory on each vaccine.